These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12920861)

  • 1. Radioimmunoscintigraphy of tumors autocrine for human met and hepatocyte growth factor/scatter factor.
    Hay RV; Cao B; Skinner RS; Wang LM; Su Y; Resau JH; Vande Woude GF; Gross MD
    Mol Imaging; 2002; 1(1):56-62. PubMed ID: 12920861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma.
    Gao CF; Xie Q; Zhang YW; Su Y; Zhao P; Cao B; Furge K; Sun J; Rex K; Osgood T; Coxon A; Burgess TL; Vande Woude GF
    Mol Cancer Ther; 2009 Oct; 8(10):2803-10. PubMed ID: 19825800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models.
    Cao B; Su Y; Oskarsson M; Zhao P; Kort EJ; Fisher RJ; Wang LM; Vande Woude GF
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7443-8. PubMed ID: 11416216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of hepatocyte growth factor/scatter factor and c-Met in human dental papilla and fibroblasts from dental papilla.
    Kajihara T; Ohnishi T; Arakaki N; Semba I; Daikuhara Y
    Arch Oral Biol; 1999 Feb; 44(2):135-47. PubMed ID: 10206332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros.
    Woolf AS; Kolatsi-Joannou M; Hardman P; Andermarcher E; Moorby C; Fine LG; Jat PS; Noble MD; Gherardi E
    J Cell Biol; 1995 Jan; 128(1-2):171-84. PubMed ID: 7822413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoscintigraphy of human met-expressing tumor xenografts using met3, a new monoclonal antibody.
    Hay RV; Cao B; Skinner RS; Wang LM; Su Y; Resau JH; Knudsen BS; Gustafson MF; Koo HM; Vande Woude GF; Gross MD
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3839S-44S. PubMed ID: 14506181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas.
    Lamszus K; Laterra J; Westphal M; Rosen EM
    Int J Dev Neurosci; 1999; 17(5-6):517-30. PubMed ID: 10571413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
    Abounader R; Ranganathan S; Lal B; Fielding K; Book A; Dietz H; Burger P; Laterra J
    J Natl Cancer Inst; 1999 Sep; 91(18):1548-56. PubMed ID: 10491431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of human naïve Fab library and characterization of anti-met Fab fragment generated from the library.
    Jiao Y; Zhao P; Zhu J; Grabinski T; Feng Z; Guan X; Skinner RS; Gross MD; Hay RV; Tachibana H; Cao B
    Mol Biotechnol; 2005 Sep; 31(1):41-54. PubMed ID: 16118414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo.
    Jakubczak JL; LaRochelle WJ; Merlino G
    Mol Cell Biol; 1998 Mar; 18(3):1275-83. PubMed ID: 9488442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis.
    Cortner J; Vande Woude GF; Rong S
    EXS; 1995; 74():89-121. PubMed ID: 8527903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin-3-gallate inhibits paracrine and autocrine hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion.
    Kwak IH; Shin YH; Kim M; Cha HY; Nam HJ; Lee BS; Chaudhary SC; Pai KS; Lee JH
    Exp Mol Med; 2011 Feb; 43(2):111-20. PubMed ID: 21209554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
    Moriyama T; Kataoka H; Koono M; Wakisaka S
    Int J Mol Med; 1999 May; 3(5):531-6. PubMed ID: 10202187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.
    Parr C; Jiang WG
    Int J Oncol; 2001 Oct; 19(4):857-63. PubMed ID: 11562767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hepatocyte growth factor/scatter factor (HGF/SF) receptor, met, transduces a morphogenetic signal in renal glomerular fibromuscular mesangial cells.
    Kolatsi-Joannou M; Woolf AS; Hardman P; White SJ; Gordge M; Henderson RM
    J Cell Sci; 1995 Dec; 108 ( Pt 12)():3703-14. PubMed ID: 8719877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
    Jeffers M; Rong S; Anver M; Vande Woude GF
    Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
    Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J
    Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor.
    Badie B; Schartner J; Klaver J; Vorpahl J
    Neurosurgery; 1999 May; 44(5):1077-82; discussion 1082-3. PubMed ID: 10232541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor.
    Takayama H; LaRochelle WJ; Sharp R; Otsuka T; Kriebel P; Anver M; Aaronson SA; Merlino G
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):701-6. PubMed ID: 9012848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.